Pharmacological characterisation of novel furoxans and furoxan-aspirin hybrid drugs in blood vessels, inflammatory cells and platelets
A novel range of hybrid drugs in which a furoxan nitric oxide (NO)-donating moiety is joined by ester linkage to the aspirin molecule were developed in the hope that the cytoprotective actions of drug-derived NO would overcome the gastric side-effects of aspirin. In addition, the presence of the NO...
| Main Author: | |
|---|---|
| Published: |
University of Edinburgh
2007
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.663095 |